Jonathan M. Peacock joined Amgen as chief financial officer in September 2010. In this role, he is responsible for finance, investor relations operations and strategy and corporate development.

Peacock joined Amgen from Novartis Pharmaceutical AG, where he had served as chief financial and administration officer since 2005. He also was responsible for IT, Purchasing, Strategic Planning and Mergers and Acquisitions at Novartis. In addition, Peacock was responsible for Novartis’ malaria program, a corporate citizenship initiative in conjunction with the major donor organizations, to supply the company’s malaria medicine at cost to countries throughout Africa.

Previously, Peacock was a partner at McKinsey and Company, working for the consulting firm’s Amsterdam, Zurich and London offices. He also was a partner at Price Waterhouse in New York and London. He has an MA degree in Economics from the University of St. Andrews in Scotland and is a Chartered Accountant.